|
본 연구는 당뇨병 환자의 자가관리의 한 방안인 운동요법으로 조깅 프로그램이 제 2형 당뇨병 환자의 당대사와 지질대사 및 심폐기능에 미치는 영향을 규명하고자 시도되었다.
비동질 대조군 사전-사후 조사로 반복처치 설계법에 의하여 제 2형 당뇨병 환자를 대상으로 실험군 대상자는 4주에 걸쳐 매주 3회씩 조깅 프로그램을 시행하였고, 대조군 대상자는 평상시의 생활을 그대로 게속한 결과, 실험군 대상자는 시행전보다 당대사와 지질대사량이 많아지고 심폐기능이 좋아졌으므로 조깅 프로그램이 제 2형 당뇨병 환자의 자가관리의 한 방안으로 사용될 수 있다. 또한 조깅 프로그램은 제 2형 당뇨병 환자에게 가장 중요한 혈당을 감소시켜 3주 후에는 허용범위로 조절하여 안정시켰으며, 총 콜레스테롤과 심장 회복률을 제외한 다른 변수에도 효과를 나타내었다.
This study was done for the purpose of testing effects of programmed jogging as one of the self care activities on glucose and lipid metabolism and cardio-pulmonary function in type ][ diabetic patients.
Research design was a repeated measure as non-equivalent control group pre-post test quasi-experimental design.
Thirty type ff diabetic patients who received follow-up care regularly at the out patient department of internal medicine in two general hospitals which had diabetic clinic were studied. Fourteen were assigned to the experimental group and sixteen to the control group. The experimental group participated in the programmed jogging 3 times per week for 4 weeks and the control group didn´t have the programmed jogging. The programmed was developed from a review of the literature done by the researcher.
Data were analyzed by X2-test, t-test, paired t-test and MANOVA using SPSS/PC
The results are summarized as follows ;
1. There were no significant difference between the experimental group and the control group for general characteristics and the pre-test of metabolism and cardiopulmonary function.
2. Hypothesis 1) that type I diabetic patients who participate in the programmed jogging will have a higher level of glucose metabolism than type U diabetic patients who don´t do programmed jogging was partly supported(FBS ; between groups F=9.57, p(.05, time within the experimental group F=24.28, p(.001, .05, HWC ; between groups t=1.09, p).05, time within the experimental group t= 2.32, p(.05).
3. Hypothesis 2) that type I diabetic patients who participate in the programmed jogging will have a higher level of lipid metabolism than type 9 diabetic patients who don´t do programmed jogging was rejected(triglyceride ; between groups F =.85, p).05, time within the experimental group F=7.87, p(.05, total cholesterol ; between groups F=4.07, p).05, time within the experimental group F=.02, p).05, HDL cholesterol ; between groups F=2.72, p.)05, time within the experimental group F=9.81, p(.05, body weight ; between groups F=2.72, p).05, time within the experimental group F=15.38, p(.001).
4. Hypothesis 3) that type I diabetic patients who participate in the programmed jogging will have better cardio-pulmonary function than type 0 diabetic patients who don´t do programmed jogging was partly supported (MVV ; between groups F =11.60, p(.05, time within the experimental group F=9.03, p(.05, FEV, ;between groups F=1.60, p).05, time within the experimental group F=13.57, p(.05).
I 5. Hypothesis 4) that there will be a significant difference in the amount of glucose metabolism before programmed jogging and after in type I diabetic patients was supported(FBS ; F=31.20, p(.001, HbA,C ; t=2.32, p.(.05).
As for the effects of programmed jogging on glucose metabolism according to the length of the jogging period ; FBS took effect after the first week and was
{
stabilized after the third week, and HbA,C took effect after the fourth week.
6. Hypothesis 5) that will be a significant difference in the amount of lipid metabolism before programmed jogging and after in type ff diabetic patients was partly supported(triglyceride ; F=22.73, p(.001, total cholesterol ; F=3.89, p).05, HDL cholesterol ; F=4.55, p).05, body weight ; F=23.75, p(.001, body fat ; F=26.38,
p(.001).
As for the effects of programmed jogging on lipid metabolism according to the length of the jogging period ; a decrease in body weight and body fat was demonstrated in each week from the first to the fourth week, triglyceride from the second to the fourth week, HDL cholesterol after the fourth week, but the total cholesterol did not decrease during the study period of four weeks.
7. Hypothesis 6) that there will be a significant difference in the cardio-pulmonary function before programmed jogging and after in type I diabetic patients was supported (systolic blood pressure ; F=6.46, p(.05, diastolic blood pressure ; F= 8.00, p(.05, heart rate at rest; F=5.80, p(.05, MVV ; F=12.81, p(.05, FEV, ; F =14.83, (.05).
As for the effects of programmed jogging on cardio-pulmonary function ac-cording to the length of the jogging period ; Diastolic blood pressure, systolic blood pressure, heart rate at last, MVV and FEV, were demonstrated in each week from the first to the fourth week. There was no change in the heart´s recovery rate regardless of the length of time of the programmed jogging.
|